Neurologist Francesco Nonino and professor Edo Richard share first-hand perspectives on researching and publishing the high-profile Cochrane review of amyloid-beta-targeting Alzheimer's drugs, covering public response, managing scientific controversy, and preserving trust in complex evidence.
Listed via the source → — verify details on the official page before applying.